HIV Prevention: Evidence-Based Education

How HIV is and is not transmitted, how testing works, and how treatment, PrEP, PEP and condoms prevent HIV—explained accurately and without stigma.

US guidance referencedHIV vs. AIDS explainedNon-stigmatizing

This website provides general educational information and does not replace professional medical advice, diagnosis, or treatment. Medical guidance and research findings may change. Consult qualified healthcare professionals for individual health concerns.

Understanding HIV

HIV, the human immunodeficiency virus, attacks the immune system—particularly CD4 cells, a type of helper T cell that coordinates immune responses. Without treatment, HIV gradually reduces the number of these cells, making the body more vulnerable to infections and certain cancers it would normally control.

It is important to distinguish HIV from AIDS. HIV is the virus; HIV infection is the condition of living with it. AIDS, acquired immunodeficiency syndrome, is the most advanced stage of untreated HIV infection. A person can live with HIV for many years without developing AIDS, and with effective antiretroviral therapy most people never do.

Global context

UNAIDS estimates that about 40.8 million people worldwide were living with HIV in 2024, and about 1.3 million people acquired HIV that year. Prevention, testing and treatment remain central public health priorities.

How HIV Transmission Occurs

HIV can be transmitted only through specific body fluids from a person who has HIV and a detectable viral load: blood, semen, pre-seminal fluid, rectal fluids, vaginal fluids and breast milk. For transmission to occur, these fluids must come into contact with a mucous membrane (such as those in the rectum, vagina, penis or mouth), damaged tissue, or be directly injected into the bloodstream.

In the United States, most HIV transmission occurs through:

  • Anal or vaginal sex without HIV prevention such as condoms, PrEP or a partner’s sustained viral suppression. Receptive anal sex carries the highest risk among sexual activities.
  • Sharing needles, syringes or other drug injection equipment.

HIV can also be passed during pregnancy, birth or breastfeeding, although antiretroviral treatment and appropriate care greatly reduce this risk. Transmission through blood transfusion is extremely rare in countries, including the United States, that screen the blood supply.

How HIV Is Not Transmitted

HIV does not survive long outside the body and cannot reproduce outside a human host. It is not transmitted through:

  • Saliva, tears or sweat
  • Hugging, shaking hands or closed-mouth kissing
  • Sharing toilets, dishes, food, drinks or towels
  • Mosquitoes, ticks or other insects
  • Air or water, including swimming pools

Ordinary social contact with a person living with HIV carries no risk of transmission. Fear based on misinformation fuels stigma and discourages people from testing and seeking care.

Understanding HIV Testing

Testing is the only way to know one’s HIV status. US CDC guidance recommends that everyone aged 13 to 64 be tested at least once as part of routine health care, and that people with ongoing risk be tested more often.

Approximate detection windows for common HIV test types, based on US CDC information. The window period differs between individuals.
Test typeWhat it detectsTypical window after exposure
Nucleic acid test (NAT)HIV genetic material in bloodAbout 10–33 days
Antigen/antibody test (laboratory, blood draw)HIV p24 antigen and antibodiesAbout 18–45 days
Antigen/antibody test (rapid, finger-stick)HIV p24 antigen and antibodiesAbout 18–90 days
Antibody testAntibodies to HIVAbout 23–90 days

A reactive result on a screening test needs a follow-up test to confirm a diagnosis. A healthcare provider or testing service can explain results and next steps.

Antiretroviral Treatment and Prevention

Antiretroviral therapy (ART) uses combinations of HIV medicines to stop the virus from replicating. ART does not cure HIV, but taken as prescribed it can reduce the amount of virus in the blood (the viral load) to levels too low for standard tests to measure. This protects the person’s immune system and health, and it also prevents sexual transmission. US guidance recommends starting ART as soon as possible after diagnosis.

Pre-Exposure Prophylaxis (PrEP)

PrEP is medication taken by people who do not have HIV to reduce their chance of acquiring it. According to the US CDC, PrEP reduces the risk of getting HIV from sex by about 99% when taken as prescribed, and reduces the risk from injection drug use by at least 74%. Effectiveness depends heavily on using PrEP as directed.

In the United States, FDA-approved PrEP options currently include daily oral pills (emtricitabine/tenofovir disoproxil fumarate, and emtricitabine/tenofovir alafenamide for some groups) and long-acting injections (cabotegravir, given every two months after initiation doses, and lenacapavir, approved by the FDA in June 2025 and given twice a year after initiation). Which option is appropriate depends on individual factors that only a clinician can assess, including HIV testing before and during use.

PrEP
Pre-exposure prophylaxis
Prevention medication used before a possible exposure. PrEP requires a negative HIV test before starting and regular follow-up testing while in use.

Post-Exposure Prophylaxis (PEP)

PEP is a short course of antiretroviral medicines taken after a possible exposure to HIV, such as sex without protection, a condom break, shared injection equipment or sexual assault. It is an emergency measure, not a replacement for regular prevention.

Time-sensitive (United States guidance)

The CDC’s 2025 recommendations state that PEP should begin as soon as possible—ideally within 24 hours and no later than 72 hours after exposure—and that the course lasts 28 days. The first dose should not be delayed while waiting for laboratory results. Anyone who may have been exposed should seek medical care immediately.

Condoms and Other Prevention Strategies

External (male) and internal (female) condoms are highly effective at preventing HIV and many other sexually transmitted infections when used consistently and correctly. Water- or silicone-based lubricants reduce the chance of condoms breaking. Other strategies include:

  • Using new, sterile needles and syringes every time, and never sharing injection equipment. Syringe services programs, where available, provide sterile supplies and links to care.
  • Regular testing and treatment for other sexually transmitted infections, which can increase HIV risk.
  • Prenatal HIV testing and treatment to prevent perinatal transmission.
  • Combining methods—for example, PrEP with condoms—for broader protection.

Undetectable Equals Untransmittable (U=U)

Large international studies, including HPTN 052, PARTNER, PARTNER2 and Opposites Attract, followed many couples in which one partner had HIV and the other did not. Among partners whose HIV was durably suppressed by treatment, no linked HIV transmissions were observed. Based on this evidence, the US CDC states that people with HIV who take treatment as prescribed and achieve and maintain an undetectable viral load have effectively no risk of transmitting HIV to sexual partners.

U=U applies to sexual transmission. It depends on continued treatment and regular viral load monitoring. U=U does not protect against other sexually transmitted infections.

Addressing HIV Stigma

HIV stigma—negative attitudes, beliefs and discrimination toward people with HIV—remains one of the greatest barriers to prevention and care. It discourages testing, delays treatment and harms mental health. Language matters: person-first terms such as “person living with HIV” are preferred over labels, and phrases that imply blame should be avoided. Accurate knowledge about how HIV is and is not transmitted is one of the most effective tools against stigma.

Accessing Appropriate Healthcare Information

Decisions about testing, PrEP, PEP and treatment should be made with a qualified healthcare professional, such as a primary care clinician, sexual health clinic, infectious disease specialist or pharmacist. Local and state health departments in the United States can provide information about testing and prevention services. This website cannot provide individual advice, diagnosis or treatment.

Frequently Asked Questions

Is HIV the same as AIDS?

No. HIV is the virus. AIDS (acquired immunodeficiency syndrome) is the most advanced stage of untreated HIV infection, diagnosed when the immune system is severely damaged—for example, a CD4 cell count below 200 cells per cubic millimeter of blood or the presence of certain opportunistic illnesses. With effective treatment, most people with HIV do not progress to AIDS.

Can I get HIV from kissing, hugging or sharing a bathroom?

No. HIV is not transmitted through saliva, sweat, tears, closed-mouth kissing, hugging, shaking hands, sharing dishes, toilets or swimming pools, or by insects such as mosquitoes.

How soon after a possible exposure can a test detect HIV?

It depends on the type of test. US CDC information indicates that laboratory nucleic acid tests can usually detect HIV about 10 to 33 days after exposure, laboratory antigen/antibody tests about 18 to 45 days after exposure, and antibody tests about 23 to 90 days after exposure. A clinician can advise when and how to test, and whether repeat testing is needed.

Does PrEP protect against other sexually transmitted infections?

No. PrEP reduces the chance of acquiring HIV only. Condoms and regular sexual health testing help reduce and detect other sexually transmitted infections.

What should I do if I think I was exposed to HIV in the last few days?

Seek medical care immediately—for example, at an emergency department, urgent care clinic or sexual health clinic. US CDC guidance recommends that PEP be started as soon as possible, ideally within 24 hours and no later than 72 hours after the exposure.

Is there a cure for HIV?

There is currently no widely available cure. A very small number of people have entered long-term remission after stem cell transplants performed to treat cancer, but this procedure carries serious risks and is not a treatment option for HIV alone. Antiretroviral therapy controls the virus effectively for most people.